Related Experiment Video
Updated: Apr 23, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Understanding Parkinson disease: an evolving case study
Gwyn M Vernon1, Anne E S Carty, Christin M Salemno
1Gwyn M. Vernon is a nurse practitioner at the Parkinson's Disease and Movement Disorders Center, University of Pennsylvania, Philadelphia, Pa. Anne E. S. Carty is a professor at Rhode Island College School of Nursing, North Providence, R.I. Christin M. Salemno is a clinical nurse at the Parkinson's Disease and Movement Disorders Center, University of Pennsylvania, Philadelphia, Pa. Michele M. Siskind is an assistant professor at Rhode Island College School of Nursing, Providence, R.I. Cathi A. Thomas is an assistant clinical professor of Neurology and program director at Parkinson's Disease and Movement Disorders Center, Boston University, Boston, Mass.
Abstract:
Thirty years ago, Parkinson disease was described as a shortage of the neurotransmitter dopamine. Today, understanding of this disorder includes possible genetic influences, premorbid and nonmotor issues, and a variety of neurologic, cognitive, and psychiatric symptoms. Using a case study, this article presents the current science of Parkinson disease.
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Alterations in Muscle Tone lll

